logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Cordenpharma Completes Acquisition Of Three Manufacturing Facilities From Vifor Pharma

Feb 01, 2022•almost 4 years ago

Acquiring Company

CordenPharma

Acquired Company

Three Manufacturing Facilities

Health Care

Description

CordenPharma, a leading, full-service Contract Development & Manufacturing Organization (CDMO) supplying APIs, Excipients, Drug Products, and associated Packaging services, announced today the completion of the acquisition of three manufacturing facilities from Vifor Pharma, to be ultimately renamed Corden Pharma Fribourg S.A. (including its Ettingen branch) in Switzerland, and Corden Pharma Lisbon S.A. in Portugal.

Company Information

Company

CordenPharma

About

CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is a full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Excipients, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under five Technology Platforms – Peptides, Lipids & Carbohydrates, Injectables, Highly Potent & Oncology, and Small Molecules – CordenPharma experts translate complex processes and projects at any stage of development into high-value products. For more information about CordenPharma, contact us or visit cordenpharma.com. Logo - https://mma.prnewswire.com/media/1173757/CordenPharma_Logo.jpg SOURCE CordenPharma

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed